1-3 of 3
Sarah A Milgrom, MD
Close
Sort by
Journal Articles

Radiation Pneumonitis Risk after Bleomycin Toxicity in Hodgkin Lymphoma Patients

Zeinab A Abou Yehia, MD, George Mikhaeel, MD, Grace Smith, MD, Chelsea C Pinnix, MDPhD, Sarah A Milgrom, MD, Michelle A. Fanale, MD, Jay Reddy, MD, Eleanor Osborne, MD, Mani Akhtari, MD, Jillian Gunther, MD, Pamela Allen, PhD, Bouthaina S. Dabaja, MD
Journal: Blood
Blood (2015) 126 (23): 1511.
https://doi.org/10.1182/blood.V126.23.1511.1511
Published: 2015
Journal Articles

Clinical Characteristics and Outcomes of Patients with Hodgkin Lymphoma with Central Nervous System Involvement: An International Multicenter Collaboration

Chan Yoon Cheah, MBBS DMedSc, Paul J Broeckelmann, MD, Alison J Moskowitz, MD, Andreas Engert, MD, Mats Jerkeman, MD PhD, Tarec Christoffer El-Galaly, Julie Vose, Diego Villa, MDMPH, Joseph M. Connors, MD, Tatyana Feldman, MD, Dai Chihara, MD PhD, Chelsea C Pinnix, MDPhD, Sarah A Milgrom, MD, Bouthaina S. Dabaja, MD, Yasuhiro Oki, MD, Michelle A. Fanale, MD
Journal: Blood
Blood (2015) 126 (23): 3865.
https://doi.org/10.1182/blood.V126.23.3865.3865
Published: 2015
Journal Articles

Prospective Phase 2 Trial of High-Dose Gemcitabine/Busulfan/Melphalan (Gem/Bu/Mel) with Autologous Stem-Cell Transplant (ASCT) without Post-ASCT Maintenance, in Hodgkins Lymphoma Patients at High Risk of Post-Transplant Recurrence Comparison with a Concurrent Matched Cohort Treated with BEAM

Yago Nieto, MD, PhD, Roland Bassett, MS, Paolo Anderlini, MD, Chitra M. Hosing, MD, Amin M. Alousi, MD, Uday R. Popat, MD, Borje S. Andersson, MD PhD, Benigno C. Valdez, PhD, Elizabeth J. Shpall, MD, Sairah Ahmed, MD, Muzaffar Qazilbash, MD, Maria Guillermo, Yasuhiro Oki, MD, Michelle A. Fanale, Fredrick B. Hagemeister, MD, Bouthaina S. Dabaja, MD, Chelsea C Pinnix, MDPhD, Sarah A Milgrom, MD, Priti Tewari, MD, Richard E. Champlin, MD, Roy Jones, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1980.
https://doi.org/10.1182/blood.V126.23.1980.1980
Published: 2015